1.
All the following are true regarding emtricitabine, except
2.
All the following are true regarding efavirenz, except
3.
All the following are true regarding ritonavir, except
4.
All the following are true regarding enfuvirtide, except
5.
All the following are true regarding dolutegravir, except
6.
All the following are true regarding maraviroc, except
7.
All the following are true regarding cobicistat, except
8.
All the following are true regarding antiretroviral therapy, except
9.
All the following are true regarding post-exposure prophylaxis (PEP) of HIV, except
10.
All the following are true regarding prophylactic treatment of infants born to HIV-infected mothers, except